“How much perjury is too much perjury from a Supreme Court nominee?”
That was how one commentator responded to a flurry of new documents and emails released on Thursday by Sens. Dianne Feinstein (D-Calif.) and Patrick Leahy (D-Vt.)that appear to show President Donald Trump’s Supreme Court pick Brett Kavanaugh lied under oath during hearings for his nomination to the U.S. Court of Appeals in 2004 and 2006.
In 2004 – after a Senate sergeant-at-arms report found that Republican staffer Manuel Miranda had stolen confidential communications and documents from Democratic senators – Kavanaugh told the Senate that he never received “documents that appeared…to have been drafted or prepared by Democratic staff members.”
Accused of mistaking her neighbor’s apartment for her own and fatally shooting him, a Dallas police officer faces a charge of manslaughter for taking the innocent man’s life. According to neighbors, the officer never issued a warning or knocked on the door prior to the shooting.
On Friday, the Dallas Police Department issued the following statement: “On September 6, 2018 at about 9:59 p.m., an off duty Dallas Police officer called police dispatch and said she was involved in a shooting at the apartments located at 1210 S. Lamar.
Supreme Court nominee Brett Kavanaugh needs to give Sen. Susan Collins (R-ME) plausible deniability regarding his anti-abortion views. Collins, who is nominally pro-choice, said shortly before Kavanaugh’s nomination that a Supreme Court nominee “who would overturn Roe v. Wade would not be acceptable to me.” But she’s spent much of the time since his nomination looking for excuses to claim that Kavanaugh’s views on Roe are uncertain.
Well, they aren’t. Even before Kavanaugh became a Supreme Court nominee, his record indicated fairly clearly that he opposes Roe. And he cleared up any remaining doubt on the second day of his confirmation hearing – despite the fact that almost no one noticed.
One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and the Lancet.
The researcher, Dr. José Baselga, a towering figure in the cancer world, is the chief medical officer at Memorial Sloan Kettering Cancer Center in New York. He has held board memberships or advisory roles with Roche and Bristol-Myers Squibb, among other corporations; has had a stake in start-ups testing cancer therapies; and played a key role in the development of breakthrough drugs that have revolutionized treatments for breast cancer.